Physician profile
Megan Monnier
NPI 1639694409
$22,891.23
in general payments reported to CMS, 2019-2025
15 companies · $4,845 in 2025
The $4,845 reported for 2025 was more than what 99% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $753 · 2022: $5,250 · 2023: $7,713 · 2024: $4,330 · 2025: $4,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,473 · Food and Beverage: $5,861 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Consulting Fee: $525 · Education: $29.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,473.29 |
| Food and Beverage | $5,861.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Consulting Fee | $525.00 |
| Education | $29.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $13,977.22 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $5,088.15 | 2021-2024 | Corevalve Evolut R |
| Boston Scientific Corporation | $3,232.29 | 2022-2025 | Watchman Access System, Watchman Flx |
| Cardiva Medical, INC. | $125.44 | 2025 | Savvywire |
| Abiomed | $91.20 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.44 | 2021-2025 | Lifevest |
| Abbott Laboratories | $65.15 | 2025 | Mitraclip |
| Novartis Pharmaceuticals Corporation | $57.29 | 2025 | |
| Pfizer INC. | $55.80 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.98 | 2025 | |
| Philips North America LLC | $33.15 | 2025 | Coronary Other |
| Merck Sharp & Dohme LLC | $17.57 | 2025 | Verquvo |
| Chiesi USA, INC. | $14.68 | 2025 | Cleviprex, Kengreal |
| Biosense Webster, INC. | $14.50 | 2023 | Nuvision Ice Catheter |
| Janssen Pharmaceuticals, INC | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Monnier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.